Genentech's Avastin is awaiting Food and Drug Administration approval after a successful phase-III clinical trial that demonstrated its effectiveness in combination with chemotherapy for treating colorectal cancer.
Undaunted by her reception at the conference, Ms. Swan went back to the other participants in the trial and suggested that they pursue a more professional tack including getting approval for the next phase of the trial from an institutional review board, just as traditional studies do.